New Pain Drug Gets FDA Nod as Safer Alternative to Addictive Opioids
Vertex Pharmaceuticals Inc. gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to hundreds of thousands of deaths.
FDA approves drug from Boston-based company to treat pain without opioid effects
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside the brain, blocking pain signals. It cannot get into the brain. The post FDA approves drug from Boston-based company to treat pain without opioid effects appeared first on Boston.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
FDA approves JournaVX, a non-opioid pain relief option for adults
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in 25 years. Developed by Vertex Pharmaceuticals, JournaVX is designed to treat moderate to severe acute pain in adults.
FDA approves non-opioid painkiller, first new class in decades
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals outside the brain. The first new class of non-opioid painkillers in more than two decades was approved by the Food and Drug Administration, the agency said Thursday.
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.
Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.
How Painkillers Could Be Vertex Pharmaceuticals' Next $10 Billion Chapter
Vertex Pharmaceuticals could soon capture $10 billion in sales of non-opioid painkillers, an analyst said Friday as Vertex stock jumped.
Justice Department Sues Walgreens Over Unlawful Opioid Prescriptions
The Justice Department filed a civil complaint against Walgreens, alleging it dispensed millions of illegal prescriptions in ...
US accuses Walgreens of filling millions of illegitimate prescriptions, including for opioids
The U.S. Justice Department has filed a lawsuit accusing Walgreens of filling millions of prescriptions for Americans over the last decade and more without a legitimate purpose, including for ...
Racial disparities in opioid prescriptions persist despite socioeconomic factors
Non-white communities had significantly less access to opioid medications commonly prescribed for moderate to severe pain ...
Justice Department sues Walgreens over opioid drug prescriptions
The Justice Department has filed a civil lawsuit against Walgreens, accusing the 124-year-old pharmacy chain of dispensing ...
University of the Pacific researchers develop extended-release opioid reversal drug
A team of researchers at the University of the Pacific has developed an injectable version of Narcan that releases the opioid ...